IFNAR1 and systemic sclerosis: While the above studies strongly implicated type I IFN as playing a pathogenic role in SSc-PAH and IPAH, further evidence was substantiated in the type I interferon α receptor 1 knockout mouse which was found to be resistant to experimental hypoxic PAH induction.